Novartis (NVS) reported Q1 core earnings Tuesday of $2.28 per diluted share, up from $1.80 a year earlier.
Analysts polled by FactSet expected $2.11.
Net sales to third parties for the quarter ended March 31 were $13.23 billion, up from $11.83 billion a year earlier.
Analysts surveyed by FactSet expected $13.08 billion.
The company said it expects full-year sales to grow in the high single digits and core operating income to grow in the low double digits.
Shares of the company rose more than 1% in recent Tuesday premarket activity.
Price: 114.05, Change: +1.42, Percent Change: +1.26
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.